Page last updated: 2024-08-25

methotrexate and Infectious Diseases

methotrexate has been researched along with Infectious Diseases in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	1 (14.29)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coskun, BN; Dalkilic, E; Ermurat, S; Pehlivan, Y; Tufan, AN; Yağız, B	1
Kelley, SO; Pereira, MP	1
Pope, JE; Rieder, SW; Thompson, AE	1
Brachemi, S; Déziel, C; Goupil, R; Lavergne, V; Nadeau-Fredette, AC; Troyanov, S; Troyanov, Y	1
White, DA	1
Kidd, PG; Loughran, TP; Starkebaum, G	1
Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM	1

Reviews

2 review(s) available for methotrexate and Infectious Diseases

Article	Year
Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis and rheumatism, 2011, Volume: 63, Issue:6 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasms; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Tumor Necrosis Factor-alpha	2011
Drug-induced pulmonary infection. Clinics in chest medicine, 2004, Volume: 25, Issue:1 Topics: Aspergillosis; Communicable Diseases; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases; Methotrexate; Pneumonia, Pneumocystis; Purine Nucleosides; Tacrolimus; Tuberculosis; Tumor Necrosis Factor-alpha	2004

Article

Year

Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Arthritis and rheumatism, 2011, Volume: 63, Issue:6

Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasms; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Tumor Necrosis Factor-alpha

2011

Drug-induced pulmonary infection.

Clinics in chest medicine, 2004, Volume: 25, Issue:1

Topics: Aspergillosis; Communicable Diseases; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases; Methotrexate; Pneumonia, Pneumocystis; Purine Nucleosides; Tacrolimus; Tuberculosis; Tumor Necrosis Factor-alpha

2004

Trials

2 trial(s) available for methotrexate and Infectious Diseases

Article	Year
Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood, 1994, Oct-01, Volume: 84, Issue:7 Topics: Administration, Oral; Adult; Aged; Communicable Diseases; Dose-Response Relationship, Drug; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunophenotyping; Leukemia, Lymphoid; Lymphocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Prospective Studies	1994
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1999, Volume: 5, Issue:5 Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous	1999

Article

Year

Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate.

Blood, 1994, Oct-01, Volume: 84, Issue:7

Topics: Administration, Oral; Adult; Aged; Communicable Diseases; Dose-Response Relationship, Drug; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunophenotyping; Leukemia, Lymphoid; Lymphocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Prospective Studies

1994

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1999, Volume: 5, Issue:5

Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous

1999

Other Studies

3 other study(ies) available for methotrexate and Infectious Diseases

Article	Year
Methotrexate intoxication: Beyond the adverse events. International journal of rheumatic diseases, 2018, Volume: 21, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Communicable Diseases; Dose-Response Relationship, Drug; Drug Interactions; Female; Fever; Humans; Male; Medication Errors; Methotrexate; Middle Aged; Mucositis; Purpura, Thrombocytopenic; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Turkey	2018
Maximizing the therapeutic window of an antimicrobial drug by imparting mitochondrial sequestration in human cells. Journal of the American Chemical Society, 2011, Mar-16, Volume: 133, Issue:10 Topics: Anti-Bacterial Agents; Biological Transport; Communicable Diseases; Escherichia coli; HeLa Cells; Humans; Methotrexate; Mitochondria; Peptides; Streptococcus pneumoniae	2011
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clinical journal of the American Society of Nephrology : CJASN, 2013, Volume: 8, Issue:3 Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Chi-Square Distribution; Communicable Diseases; Cyclophosphamide; Female; Hospitals, University; Humans; Immunocompromised Host; Immunosuppressive Agents; Kaplan-Meier Estimate; Linear Models; Lymphocyte Count; Lymphopenia; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Neutropenia; Plasmapheresis; Quebec; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome	2013